WallStSmart

American Healthcare REIT, Inc. (AHR)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

American Healthcare REIT, Inc. generates 772% more annual revenue ($2.26B vs $258.90M). AHR leads profitability with a 3.1% profit margin vs -15.5%. AHR earns a higher WallStSmart Score of 46/100 (D+).

AHR

Hold

46

out of 100

Grade: D+

Growth: 6.0Profit: 4.5Value: 3.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.62

ZEPP

Hold

43

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHRSignificantly Overvalued (-162.1%)

Margin of Safety

-162.1%

Fair Value

$19.66

Current Price

$47.94

$28.28 premium

UndervaluedFair: $19.66Overvalued

Intrinsic value data unavailable for ZEPP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHR1 strengths · Avg: 8.0/10
Price/BookValuation
2.7x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

AHR4 concerns · Avg: 3.0/10
EPS GrowthGrowth
3.1%4/10

3.1% earnings growth

Return on EquityProfitability
2.5%3/10

ROE of 2.5% — below average capital efficiency

Profit MarginProfitability
3.1%3/10

3.1% margin — thin

P/E RatioValuation
114.9x2/10

Premium valuation, high expectations priced in

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$216.30M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : AHR

The strongest argument for AHR centers on Price/Book. Revenue growth of 11.9% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : AHR

The primary concerns for AHR are EPS Growth, Return on Equity, Profit Margin. A P/E of 114.9x leaves little room for execution misses. Thin 3.1% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

AHR profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.59 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor REIT - HEALTHCARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AHR scores higher overall (46/100 vs 43/100) and 11.9% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American Healthcare REIT, Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

American Healthcare REIT, Inc. is a prominent real estate investment trust focused on the acquisition and management of a diversified portfolio of high-quality healthcare facilities across the United States. Specializing in senior housing, skilled nursing, and medical office properties, the company collaborates with leading operators to guarantee stable cash flows and sustainable growth. By prioritizing the enhancement of resident and patient quality of life, American Healthcare REIT is strategically positioned to benefit from the expanding healthcare real estate sector, presenting a compelling investment opportunity for institutional investors in an essential services market.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?